Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MGLL | Q99685 | 3/20 | 0.32 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7153238 | 0.81 | ALDH1A1 (0.44) | TP53CYP3A4ALDH1A1MGLLIRAK4 | |
| SCHEMBL4807514 | 0.81 | TP53 (0.62) | TP53CYP3A4ALDH1A1MGLL | |
| SCHEMBL12234487 | 0.79 | ALDH1A1 (0.43) | TP53CYP3A4ALDH1A1MGLL | |
| SCHEMBL18691824 | 0.79 | ALDH1A1 (0.43) | TP53CYP3A4ALDH1A1MGLLIRAK4 | |
| SCHEMBL9106972 | 0.78 | ALDH1A1 (0.42) | TP53CYP3A4ALDH1A1MGLLIRAK4 | |
| SCHEMBL1866306 | 0.78 | ALDH1A1 (0.39) | ALDH1A1LMNAPOLB | |
| SCHEMBL21804854 | 0.78 | ALDH1A1 (0.47) | TP53CYP3A4ALDH1A1MGLLLMNA | |
| SCHEMBL16244518 | 0.78 | ALDH1A1 (0.42) | TP53CYP3A4ALDH1A1MGLLIRAK4 | |
| SCHEMBL9724896 | 0.78 | ALDH1A1 (0.50) | TP53CYP3A4ALDH1A1MGLLIRAK4 | |
| SCHEMBL18030278 | 0.77 | ALDH1A1 (0.45) | TP53CYP3A4ALDH1A1IRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3564227-B1 | METHOD FOR PRODUCING GLYCERIC ACID ESTER DERIVATIVES | KAO CORP (JP) | 2022-02-23 | — | — | EP | disclosed |
| EP-3564226-B1 | METHOD FOR PRODUCING GLYCERIC ACID ESTER | KAO CORP (JP) | 2021-06-02 | — | — | EP | disclosed |
| US-10870643-B2 | Method for manufacturing 1,3-dioxane-5-one | KAO CORPORATION (JP) | 2020-12-22 | — | — | US | disclosed |
| US-10870643-B2 | Method for manufacturing 1,3-dioxane-5-one | KAO CORPORATION (JP) | 2020-12-22 | — | — | US | disclosed |
| US-10829482-B2 | Method for producing glyceric acid ester | KAO CORPORATION (JP) | 2020-11-10 | — | — | US | disclosed |
| US-10829482-B2 | Method for producing glyceric acid ester | KAO CORPORATION (JP) | 2020-11-10 | — | — | US | disclosed |
| US-10822329-B2 | Method for producing glyceric acid ester | KAO CORPORATION (JP) | 2020-11-03 | — | — | US | disclosed |
| US-10822329-B2 | Method for producing glyceric acid ester | KAO CORPORATION (JP) | 2020-11-03 | — | — | US | disclosed |
| US-10710990-B2 | — | — | 2020-07-14 | — | — | US | disclosed |
| US-10710990-B2 | — | — | 2020-07-14 | — | — | US | disclosed |
| US-20200087290-A1 | METHOD FOR PRODUCING GLYCERIC ACID ESTER | KAO CORPORATION (JP) | 2020-03-19 | — | — | US | disclosed |
| EP-3564228-A1 | METHOD FOR MANUFACTURING 1,3-DIOXANE-5-ONE | Kao Corporation (JP) | 2019-11-06 | — | — | EP | disclosed |
| EP-3564227-A1 | METHOD FOR PRODUCING GLYCERIC ACID ESTER | Kao Corporation (JP) | 2019-11-06 | — | — | EP | disclosed |
| EP-3564226-A1 | METHOD FOR PRODUCING GLYCERIC ACID ESTER | Kao Corporation (JP) | 2019-11-06 | — | — | EP | disclosed |
| US-20190330173-A1 | METHOD FOR MANUFACTURING 1,3-DIOXANE-5-ONE | KAO CORPORATION (JP) | 2019-10-31 | — | — | US | disclosed |
| US-20190330173-A1 | METHOD FOR MANUFACTURING 1,3-DIOXANE-5-ONE | KAO CORPORATION (JP) | 2019-10-31 | — | — | US | disclosed |
| US-20190322654-A1 | METHOD FOR PRODUCING GLYCERIC ACID ESTER | KAO CORPORATION (JP) | 2019-10-24 | — | — | US | disclosed |
| US-20190322654-A1 | METHOD FOR PRODUCING GLYCERIC ACID ESTER | KAO CORPORATION (JP) | 2019-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190330173-A1 | METHOD FOR MANUFACTURING 1,3-DIOXANE-5-ONE | AOX1, HAO2, HAO1 | TP53 4667/4885CYP3A4 199/4885ALDH1A1 134/4885 |
| US-10822329-B2 | Method for producing glyceric acid ester | GK, GRHPR, DGAT1 | TP53 4173/4885CYP3A4 730/4885ALDH1A1 847/4885 |
| US-20200087290-A1 | METHOD FOR PRODUCING GLYCERIC ACID ESTER | GK, GRHPR, DGAT1 | TP53 4173/4885CYP3A4 730/4885ALDH1A1 847/4885 |
| US-10870643-B2 | Method for manufacturing 1,3-dioxane-5-one | AOX1, HAO2, DUOX1 | TP53 4605/4885CYP3A4 198/4885ALDH1A1 124/4885 |
| US-10710990-B2 | — | CBR1, POR, CYP11B1 | TP53 4175/4885CYP3A4 341/4885ALDH1A1 767/4885 |
| US-20190322654-A1 | METHOD FOR PRODUCING GLYCERIC ACID ESTER | GRHPR, HAO2, POR | TP53 4083/4885CYP3A4 379/4885ALDH1A1 793/4885 |
| US-10829482-B2 | Method for producing glyceric acid ester | GRHPR, HAO2, POR | TP53 4083/4885CYP3A4 379/4885ALDH1A1 793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.